AXLA

Axcella Health Inc. [AXLA] Stock Forecast

Q: What is Axcella Health Inc. stock symbol ?

Axcella Health Inc. is a US stock, located in Cambridge of Ma and trading under the symbol AXLA

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

AXLA Stock Summary

EPS has been increasing for the past 3 years (Yearly statements)

EPS has been increasing for the past 3 quarters (Quarter statements)

In the last year, shareholders have seen their holdings diluted. Dilution over past year is 39.67%

AXLA has less than 1 year of cash runway

Top 10 Correlated ETFs

AXLA

Top 10 Correlated Stocks

AXLA

In the News

11:28 29 Sep 2023 AXLA

Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now

The biotech sector never fails to offer up stocks full of massive issues at any given time. Developing novel therapeutic devices and pharmaceuticals is, after all, very expensive.

11:17 29 Sep 2023 AXLA

Are Medical Stocks Lagging Axcella Health (AXLA) This Year?

Here is how Axcella Health Inc. (AXLA) and Clover Health Investments, Corp. (CLOV) have performed compared to their sector so far this year.

09:01 29 Sep 2023 AXLA

Why Is Axcella Health (AXLA) Stock Down 24% Today?

Axcella Health (NASDAQ: AXLA ) stock is taking a beating on Friday after the biotechnology company announced plans for a reverse stock split. According to Axcella Health, shares of AXLA stock are going to undergo a one-for-25 reverse split.

09:05 29 Sep 2023 AXLA

Why Is Axcella Health (AXLA) Stock Down 21% Today?

Axcella Health (NASDAQ: AXLA ) stock is falling on Thursday following its announcement of a new Covid-19 treatment patent. However, it's not that this is bad news for the clinical-stage biotechnology company.

10:31 29 Sep 2023 AXLA

Axcella (AXLA) Up on Patent Grant for Long Covid Fatigue Drug

Axcella (AXLA) shares surge 299% after the company secures a methods-of-use patent for its lead candidate, AXA1125, which is currently under development to treat fatigue associated with Long Covid.

01:19 29 Sep 2023 AXLA

Why Is Axcella Health (AXLA) Stock Up 280% Today?

A little-known penny stock is among the market's top movers today. Axcella Health (NASDAQ: AXLA ) stock surged by as much as 280% on news that it has been granted an important new patent.

09:28 29 Sep 2023 AXLA

Axcella Health stock rockets on long Covid patent win

Axcella Health Inc (NASDAQ:AXLA) saw its stock rocket some 240% higher in Tuesday's early deals after the small-cap firm announced it had secured a patent for its treatment for ‘long' Covid fatigue. The company, in a statement, said its treatment candidate AXA1125, based on compositions of ‘endogenous metabolic modulators' (otherwise referred to as EMMs) had been granted a patent from the US Patent and Trademark Office.

08:04 29 Sep 2023 AXLA

Why Is Axcella Health (AXLA) Stock Up 68% Today?

Axcella Health (NASDAQ: AXLA ) stock is rocketing higher on Tuesday despite a lack of news from the clinical-stage biotechnology company. There are no new press releases or filings with the Securities and Exchange Commission (SEC) that would act as a catalyst for today's rally.

07:35 29 Sep 2023 AXLA

Why Is Axcella Health (AXLA) Stock Up 35% Today?

Axcella Health (NASDAQ: AXLA ) stock is on the rise Wednesday as investors react to an update from the FDA. That update has to do with the company's Long Covid Fatigue treatment currently in development.

09:28 29 Sep 2023 AXLA

Penny Stocks To Buy Now? 7 To Watch With Big News this Week

Penny stocks with news that has turned heads in the stock market this week. The post Penny Stocks To Buy Now?

AXLA Financial details

Company Rating

Buy

Market Cap

30.51M

Income

-50.03M

Revenue

Book val./share

-0.03

Cash/share

0.12

Dividend

Dividend %

Employees

Optionable

Shortable

Yes

Earnings

30 Oct 2023

P/E

-10.18

Forward P/E

PEG

2.08

P/S

P/B

-225.5

P/C

P/FCF

-0.47

Quick Ratio

0.77

Current Ratio

0.8

Debt / Equity

-0.62

LT Debt / Equity

EPS (TTM)

-0.9

EPS next Y

EPS next Q

EPS this Y

-13.64%

EPS next Y

EPS next 5Y

EPS last 5Y

Revenue last 5Y

Revenue Q/Q

EPS Q/Q

-9.57%

SMA20

50%

SMA50

80%

SMA100

-10%

Inst Own

65.07%

Inst Trans

0.98%

ROA

-539%

ROE

4068%

ROC

20.27%

Gross Margin

Oper. Margin

Profit Margin

Payout

Shs Outstand

2.95M

Shs Float

1.07M

Target Price

52W Range

2.5875-49.25

52W High

-79.43%

52W Low

+404.01%

RSI

Rel Volume

6.89

Avg Volume

824.62K

Volume

5.68M

Perf Week

-2.7%

Perf Month

142.89%

Perf Quarter

-11.81%

Perf Half Y

-8.36%

Beta

1.28903

Volatility

1.33%, 7.34%

Prev Close

45.88%

Price

10.0801

Change

42.58%

AXLA Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Revenue per share	0	0	0	0	0
Net income per share	-2.18	-3.61	-1.85	-1.76	-1.52
Operating cash flow per share	-1.86	-3.07	-1.57	-1.42	-1.28
Free cash flow per share	-1.9	-3.07	-1.58	-1.43	-1.29
Cash per share	4.81	5.54	3.38	1.44	0.32
Book value per share	2.94	3.62	2.37	0.58	0.08
Tangible book value per share	2.94	3.62	2.37	0.58	0.08
Share holders equity per share	2.94	3.62	2.37	0.58	0.08
Interest debt per share	1.48	1.7	0.89	0.73	0.1
Market cap	5.7B	1.67B	4.12B	1.99B	445.72M
Enterprise value	5.65B	1.6B	4.07B	1.99B	430.73M
P/E ratio	-158.09	-27.79	-70.04	-29.67	-5.41
Price to sales ratio	0	0	0	0	0
POCF ratio	-185.67	-32.7	-82.76	-36.73	-6.41
PFCF ratio	-181.77	-32.62	-82.37	-36.54	-6.37
P/B Ratio	117.54	27.67	54.65	90.48	107.04
PTB ratio	117.54	27.67	54.65	90.48	107.04
EV to sales	0	0	0	0	0
Enterprise value over EBITDA	-172.12	-27.87	-75.65	-32.22	-6.43
EV to operating cash flow	-183.88	-31.39	-81.83	-36.75	-6.19
EV to free cash flow	-180.02	-31.3	-81.44	-36.57	-6.15
Earnings yield	-0.01	-0.04	-0.01	-0.03	-0.18
Free cash flow yield	-0.01	-0.03	-0.01	-0.03	-0.16
Debt to equity	0.51	0.41	0.33	1.14	0.52
Debt to assets	0.3	0.26	0.23	0.43	0.11
Net debt to EBITDA	1.67	1.17	0.86	-0.02	0.22
Current ratio	11.62	11.02	13.79	5.42	1.21
Interest coverage	0	-16.92	-17.9	-21.2	-25.48
Income quality	0.85	0.86	0.88	0.84	0.86
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0.02	0	0	0.01	0.01
Capex to revenue	0	0	0	0	0
Capex to depreciation	-0.62	-0.21	-0.57	-0.95	-1.03
Stock based compensation to revenue	0	0	0	0	0
Graham number	12	17.15	9.95	4.78	1.62
ROIC	-0.44	-0.69	-0.56	-1.36	-9.2
Return on tangible assets	-0.44	-0.64	-0.54	-1.16	-4.35
Graham Net	2.79	3.48	2.3	0.51	0.04
Working capital	73.39M	83.7M	99.55M	44.9M	3M
Tangible asset value	48.51M	60.22M	75.38M	22.01M	4.16M
Net current asset value	46.97M	57.92M	73.12M	19.33M	2.38M
Invested capital	0.51	0.41	0.33	1.14	0.52
Average receivables	0	0	0	0	0
Average payables	1.32M	1.81M	2.14M	3.3M	4.5M
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	0	0	0	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0	0	0	0	0
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	-0.74	-1	-0.78	-3.05	-19.78
Capex per share	-0.04	-0.01	-0.01	-0.01	-0.01

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric	2022-06-30	2022-09-30	2022-12-31	2023-03-31	2023-06-30
Revenue per share	0	0	0	0	0
Net income per share	-0.42	-0.35	-0.45	-0.05	-0.05
Operating cash flow per share	-0.35	-0.35	-0.29	-0.07	-0.05
Free cash flow per share	-0.36	-0.36	-0.29	-0.07	-0.05
Cash per share	0.84	0.48	0.32	0.17	0.12
Book value per share	0.18	-0.14	0.08	0.01	-0.03
Tangible book value per share	0.18	-0.14	0.08	0.01	-0.03
Share holders equity per share	0.18	-0.14	0.08	0.01	-0.03
Interest debt per share	0.55	0.54	0.05	0.02	0.02
Market cap	2.67B	2.25B	445.72M	884.03M	401.6M
Enterprise value	2.66B	2.25B	430.73M	873.27M	394.11M
P/E ratio	-30.35	-30.27	-4.59	-58.64	-29.42
Price to sales ratio	0	0	0	0	0
POCF ratio	-143.05	-121.52	-28.69	-173.17	-109.85
PFCF ratio	-142.76	-120.19	-28.65	-173.17	-109.85
P/B Ratio	287.19	-298.01	107.04	1.22K	-177.86
PTB ratio	287.19	-298.01	107.04	1.22K	-177.86
EV to sales	0	0	0	0	0
Enterprise value over EBITDA	-129.21	-133.44	-39.28	-208.77	-115.81
EV to operating cash flow	-142.73	-121.63	-27.72	-171.06	-107.8
EV to free cash flow	-142.44	-120.3	-27.69	-171.06	-107.8
Earnings yield	-0.01	-0.01	-0.05	0	-0.01
Free cash flow yield	-0.01	-0.01	-0.03	-0.01	-0.01
Debt to equity	3.02	-3.65	0.52	2.46	-0.62
Debt to assets	0.56	0.9	0.11	0.14	0.15
Net debt to EBITDA	0.29	-0.13	1.37	2.57	2.2
Current ratio	2.59	1.23	1.21	1.05	0.8
Interest coverage	-27.42	-20.64	-28.42	20.21	0
Income quality	0.88	1.04	0.68	1.28	1.07
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0.01	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	-0.46	-1.56	-0.16	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	1.29	1.07	0.88	0.11	0.18
ROIC	-0.53	-0.79	-2.6	-0.92	-6.76
Return on tangible assets	-0.44	-0.6	-1.28	-0.3	-0.37
Graham Net	0.07	-0.25	0.04	0.01	-0.04
Working capital	27.23M	5.12M	3M	646K	-2.27M
Tangible asset value	9.3M	-7.55M	4.16M	727K	-2.26M
Net current asset value	3.72M	-11.11M	2.38M	502K	-2.27M
Invested capital	3.02	-3.65	0.52	2.46	-0.62
Average receivables	0	0	0	0	0
Average payables	4.42M	3.81M	4.17M	6.43M	8.27M
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	0	0	0	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0	0	0	0	0
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	-2.37	2.46	-5.83	-5.18	1.51
Capex per share	0	0	0	0	0

AXLA Frequently Asked Questions

What is Axcella Health Inc. stock symbol ?

Axcella Health Inc. is a US stock , located in Cambridge of Ma and trading under the symbol AXLA

Is Axcella Health Inc. buy or a sell ?

1 stock analysts have 1 predictions with a medium analyst target price of $6. The lowest prediction is $6 and the highest is $6

What is AXLA stock prediction ?

What is Axcella Health Inc. stock quote today ?

Axcella Health Inc. stock price is $10.0801 today.

Is Axcella Health Inc. stock public?

Yes, Axcella Health Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 824.62K
Market Capitalization 30.51M
Employee 11
CEO Mr. William R. Hinshaw Jr.
Headquarters Cambridge,MA,US
IPO Date 2019-05-09
Website https://www.axcellahealth.com

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.